Megrix Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Patients should be instructed to strictly adhere to the recommended dosage and administration guidelines set forth in this literature and on your prescription label.

  • Accidental Exposure in Children: the potential exists for a small child or a pet to suffer adverse effects from chewing or ingesting a new or used Megrix biofrequency chip. It is important for patients to store and dispose of Megrix biofrequency chips out of the reach of children and pets.
  • For external use only.
  • Although the Megrix biofrequency chip contains low frequency waves, it has not been studied with a cardiac pacemaker or defibrillator. Consultation with the attending cardiologist is recommended for patients with implanted electrical devices.
  • The Megrix biofrequency chip should be removed prior to any imaging procedures (e.g. CT scan, MRI, X-ray etc.).
  • The Megrix biofrequency chip should not be used if there are mental or physical conditions that may preclude compliance with physician instructions.


  • When traveling by air, do not wear the Megrix biofrequency chip when passing through passenger screening devices or the biofrequency chip could be damaged.
  • Application to broken or inflamed skin, although not tested, may result in higher blood concentrations from increased absorption. Megrix is only recommended for use on intact skin.
  • The contact of Megrix biofrequency chips with eyes, although not studied, should be avoided based on the findings of severe eye irritations with the use of similar products in animals. If eye contact occurs, immediately wash out the eye with water or saline.

The safety of Megrix biofrequency chip has not been established during pregnancy.

The most common adverse reactions are application site reactions, including dermatitis, itching or scaling. These tend to be dose-limiting and diminish with time.

There have been no reports of over-dosage with Megrix biofrequency chip. Signs of overdosage could include vomiting, drowsiness, coma, respiratory depression, and seizures. In the case of an overdosage, discontinue the product immediately, treat the patient symptomatically, and institute supportive measures.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Megrix medicated biofrequency chip is a topical formulation used to assist patients greater than 12 years in age in the management of mild to moderate, acute or chronic migraine headache. Megrix medicated biofrequency chips can also be used for the temporary relief of minor aches and muscle pains. Megrix biofrequency chips should be administered to the right and left temple area twice daily, or as directed every 12 hours. Use with caution when applying in order to avoid eye contact.

Remain hydrated: The Megrix biofrequency chip performs optimally when the body is adequately hydrated and contains normal levels of electrolytes such as calcium, sodium, potassium, and magnesium. On average men need 3.7 liters and women need 2.7 liters of fluids per day to remain properly hydrated.


There is currently no drug history available for this drug.

Other Information

Megrix is a topical dosage form containing 30 medicated biofrequency chips (2 disc-shaped chips on individually wrapped cards X 15 per box of 30). Megrix (Menthol 5%/Capsaicin 0.0375%) is comprised of an adhesive material containing Menthol and Capsaicin which is applied to a biofrequency chip backing and secured on an application card. Two biofrequency chips are removed from the application card and applied to the skin. The card is discarded after removing the biofrequency chips. The diameter of each disc-shaped medicated biofrequency chip is .91 inches (2.3 cm). Menthol is present in a 5% concentration. Menthol is chemically designated as 2-Isopropyl-5-methylcyclohexanol. It is colorless, hexagonal crystals, usually needle-like; fused masses or crystalline powder with a pleasant, peppermint-like odor. It has a melting point between 31°C to 36° C. Capsaicin is present in a 0.0375% concentration. Capsaicin is chemically designated as (6E)-N-(4-Hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide. It is crystalline white powder. It has a melting point of 65° C. It also contains the following inactive ingredients: Polyester-7, Aluminum Acetate, Ethyl Cyanoacrylate, Paraffin, and Propylene Glycol

The disc-shaped biofrequency chip dosage form is programed with bioactive frequencies using longitudinal electromagnetic (scalar) waves that complement the active ingredients menthol and capsaicin.

Megrix Manufacturers

  • Basiem
    Megrix (Menthol Capsaicin) Disc [Basiem]

Login To Your Free Account